专家论坛

2005年至2018年皮肤淋巴瘤WHO-EORTC分类标准的发展与比较

展开
  • 上海交通大学医学院附属瑞金医院皮肤科,上海 200025

收稿日期: 2021-02-10

  网络出版日期: 2022-06-28

本文引用格式

沈小雁, 郑捷 . 2005年至2018年皮肤淋巴瘤WHO-EORTC分类标准的发展与比较[J]. 诊断学理论与实践, 2021 , 20(01) : 15 -20 . DOI: 10.16150/j.1671-2870.2021.01.003

参考文献

[1] Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas[J]. Blood, 2005, 105(10):3768-3785.
[2] Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer[J]. Blood. 1997 Jul 1; 90(1):354-371.
[3] Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues[M]. Lyon, France: IARC Press, 2001.
[4] Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J]. Blood, 2016, 127(20):2375-2390.
[5] Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas[J]. Blood, 2019, 133(16):1703-1714.
[6] Tomasini D, Berti E. Subcutaneous panniculitis-like T-cell lymphoma[J]. G Ital Dermatol Venereol, 2013, 148(4):395-411.
[7] Hodak E, Amitay-Laish I, Atzmony L, et al. New insights into folliculotropic mycosis fungoides (FMF): a single-center experience[J]. J Am Acad Dermatol, 2016, 75(2):347-355.
[8] Savage KJ, Harris NL, Vose JM, et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project[J]. Blood, 2008, 111(12):5496-5504.
[9] Parrilla Castellar ER, Jaffe ES, Said JW, et al. ALK-ne-gative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes[J]. Blood, 2014, 124(9):1473-1480.
[10] Vasmatzis G, Johnson SH, Knudson RA, et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas[J]. Blood, 2012, 120(11):2280-2289.
[11] Wada DA, Law ME, Hsi ED, et al. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies[J]. Mod Pathol, 2011, 24(4):596-605.
[12] Cohen JI, Iwatsuki K, Ko YH, et al. Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting[J]. Leuk Lymphoma, 2020, 61(4):808-819.
[13] Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research[J]. Hematology Am Soc Hematol Educ Program, 2009:523-531.
[14] Quintanilla-Martinez L, Ridaura C, Nagl F, et al. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma[J]. Blood, 2013, 122(18):3101-3110.
[15] Hathuc VM, Hristov AC, Smith LB. Primary Cutaneous Acral CD8+ T-Cell Lymphoma[J]. Arch Pathol Lab Med, 2017, 141(11):1469-1475.
[16] Cetinözman F, Jansen PM, Willemze R. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma[J]. Am J Surg Pathol, 2012, 36(1):109-116.
[17] Deconinck E, Petrella T, Garnache Ottou F. Blastic plasmacytoid dendritic cell neoplasm: clinical presentation and diagnosis[J]. Hematol Oncol Clin North Am, 2020, 34(3):491-500.
[18] Edinger JT, Kant JA, Swerdlow SH. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets[J]. Am J Surg Pathol, 2010, 34(12):1830-1841.
[19] Gru AA, Jaffe ES. Cutaneous EBV-related lymphoproli-ferative disorders[J]. Semin Diagn Pathol, 2017, 34(1):60-75.
文章导航

/